Colon Carcinoma in a Child Treated with Oxaliplatin and Antiangiogenic Treatment Regimens

Nada Krstovski

Lidija Dokmanovic

Jelena LazicDepartment of Hematology and Oncology, University Children's Hospital, Belgrade, Serbia

Predrag RodicDepartment of Hematology and Oncology, University Children's Hospital, Belgrade, Serbia

Lejla ParipovicDepartment of Pediatric Oncology, Institute of Oncology and Radiology, Belgrade, Serbia

Dragana JanicCorrespondence[email protected]

REFERENCES

Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Paediatr Drugs. 2008;10(3):177–192.
PubMedGoogle Scholar
National Comprehensive Cancer Network. Colon Cancer: NCCN Clinical Practice Guidelines in Oncology. Fort Washington, PA: National Comprehensive Cancer Network; 2009. http://www.nccn.org/ professionals/physician_gls/pdf/colon.pdf. Accessed 15 June 2009.
Google Scholar
Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352(5):476–487.
PubMed Web of Science ®Google Scholar
Rothenberg ML, Cox JV, Butts C, Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Ann Oncol. 2008;19(10):1720–1726.
PubMed Web of Science ®Google Scholar
Widakowich C, de Castro G, Jr, de Azambuja E, Dinh P, Awada A. Review: side effects of approved molecular targeted therapies in solid cancers. Oncologist. 2007;12(12):1443–1455.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Colon Carcinoma in a Child Treated with Oxaliplatin and Antiangiogenic Treatment Regimens

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Colon Carcinoma in a Child Treated with Oxaliplatin and Antiangiogenic Treatment Regimens

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date